Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Theseus AI is a private U.S. healthtech company developing artificial intelligence software for medical imaging, with an initial focus on spine MRI interpretation and decision support for chronic back pain and spinal stenosis. The company was formed to commercialize UCLA-licensed technology that automatically analyzes spine anatomy and disease features from MRI scans, helping radiologists, primary care physicians, and surgeons make more objective treatment decisions. Its products and research have centered on identifying surgical candidacy, quantifying spinal stenosis, and improving referral and treatment workflows. More recently, the company website presents Theseus AI more broadly as an applied AI company spanning medical vision, legal insight, startup intelligence, and embodied AI, suggesting a wider platform positioning beyond its original spine-focused healthcare application. For a biotech or healthcare analyst, Theseus AI is best understood as an active private healthcare AI/software company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Theseus AI.